期刊文献+

槲皮素在壳聚糖作用下的异构化 被引量:2

Tautomerization of Quercetin Induced by Chitosan
在线阅读 下载PDF
导出
摘要 用紫外可见光谱法研究水溶性壳聚糖在甲醇 /水 ( 1∶1,V∶V)溶液中和黄酮类化合物槲皮素之间的氢键相互作用 ,通过改变壳聚糖结构单元与槲皮素分子之间的摩尔配比进行测试 ,结合闭壳受限Hartree Fock的分子轨道 (RHF)理论方法和组态单线态相互作用法 (CIS)对槲皮素分子共振结构的量子化学计算结果 ,可以认为槲皮素在溶液中是以醌式构型存在的 ,而壳聚糖通过氢键作用使槲皮素异构成为苯甲酰构型 .这种作用结果与壳聚糖结构单元的摩尔含量、作用时间呈线性增强的趋势 .高分辨NMR的结果说明其强烈的相互作用是存在的 . The hydrogen-bonding interaction between soluble chitosan and one of the flavonoids, quercetin, was investigated by Ultra-violet and visible spectroscopy. The unit molar ratio of chitosan to quercetin was changed in a series of tests, and the quantum chemistry methods, Closed-shell Restricted Hartree-Fock (RHF) theory and Configuration Interaction Singlet (CIS) theory, were applied to compute the resonant structures of quercetin molecule. The results showed that. the quercetin as quinone configuration in solution could be tautomerized into. benzoyl configuration through hydrogen. bonding with the added chitosan. This effect was strengthened linearly with the increase of unit molar concentration of chitosan and interaction time.
出处 《化学学报》 SCIE CAS CSCD 北大核心 2003年第4期614-618,共5页 Acta Chimica Sinica
基金 国家自然科学基金 (No.2 0 1 740 1 8)
关键词 槲皮素 壳聚糖 异构化 紫外可见光谱 组态相互作用法 黄酮类化合物 中药 化学结构 quercetin chitosan ultraviolet and visible spectroscopy method of Configuration Interaction Singlet
  • 相关文献

参考文献8

  • 1Ormrod, D. J.; Holmes, C. C.; Miller, T. E. J. Atherosclerosis 1998, 138, 329.
  • 2马建标,王利民,李建敏,赵存祥,史作清,何炳林.若干极性树脂对黄芩甙及黄芩黄素的吸附性能研究[J].高等学校化学学报,1992,13(5):705-708. 被引量:7
  • 3Tsuguhei, K.; Tatsuaki, Y. JP 09 031104, 1997 [ Chem. Abstr.1997, 126, 226737].
  • 4Rao, C. N. R. Ultra-Violet and Visible Spectroscopy, Chemical Applications, 3rd Ed., Butterworths & Co. (Publishers) Ltd,London-Boston, 1975, pp. 210~212.
  • 5Wiberg, K. B.; Hadad, C. M.; Le Page, T. J. J. Phys.Chem. 1992, 96, 671.
  • 6Foresman, J. B.; Head-Gordon, M.; Pople, J. A. J. Phys.Chem. 1992, 96, 135.
  • 7易大年 徐光漪.核磁共振波谱-在药物分析中的应用[M].上海:上海科学技术出版社,1985.293.
  • 8Harborne, J. B.; Mabry, T. J.; Mabry, H. The Flavonoids, tr.by Dai, L.-K.; Xie, Y.-R., Science Press, Beijing, 1983, pp.51 - 58 (in Chinese).([英]J.B.哈本等编,戴伦凯,谢玉如译,黄酮类化合物,科学出版社,北京,1983,pp.51-58.)

二级参考文献8

  • 1马建标,离子交换与吸附,1992年,8卷,1页
  • 2马建标,1991年
  • 3马建标,高分子学报,1991年,6期,693页
  • 4马建标,中国科学.B,1991年,8期,785页
  • 5黄培源,药学通报,1990年,15卷,4页
  • 6团体著者,中草药有效成分提取与分离(第2版),1983年
  • 7陈欣方,吉林大学自然科学学报,1982年,2期,127页
  • 8曾广方,药学学报,1957年,5卷,47页

共引文献7

同被引文献31

  • 1武欣,赵宝民,李炜.丹参酚酸B盐联合黄芪多糖预处理对大鼠脑缺血再灌注细胞凋亡及GFAP表达的影响[J].河北北方学院学报(自然科学版),2013,29(4):59-62. 被引量:4
  • 2ZHANG Jun-Ping,WU Tang-Ming,HU Zhen-Lin,QIAN Ding-Hua.Inhibitory effect of quercetin on tumor necrosis factor and interleukin-1βpro-osteoclastic activities[J].中国药理学报,1996,17(3):261-263. 被引量:10
  • 3[1]Pastor JC.Proliferative vitreoretinopathy:an overview[J].Surv Ophthalmol,1998;43:3-18.
  • 4[3]Jaffe GJ,Van Le L,Valea F,et al.Expression of interleukin-1 alpha,interleukin-1 beta,and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells[J].Exp Eye Res,1992;55 (2):325-335.
  • 5[4]Charteris DG.Proliferative vitreoretinopathy:Path o biology,surgical management and adjunctive treatment[J].Br J Ophthalmol,1995;79:953-960.
  • 6[5]Bochaton-Piallat ML,Kapetanios A,Donati G,et al.TGF-b1,TGFb receptor Ⅰ and DE-A fibronectin expression in myofibroblasts of vitreoretinopathy[J].Invest Ophthamol Vis Sci,2000;41:2336-2342.
  • 7[6]Kekul,Dennis.Proliferative diabetic retinopathy[J].International Ophthalmology Clinics,2004;44(4):69-84.
  • 8[7]Khaled,michael.Retinopathy of Prematurity:Practical Surgical Management in the New Millennium[J].Techniques in Opthalmology,2004;2(2):60-65.
  • 9[10]Rubsamen PE,Cousins SW.Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy[J].Retina,1997(17):44-50.
  • 10[11]Jonas JB,Hayler JK,Panda-Jonas S.Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy[J].Br J Ophthalmol,2000; (84):1064-1066.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部